Shape Therapeutics
About:
A biotechnology company developing RNA technologies to shape the future of gene therapy
Website: https://www.shapetx.com/
Twitter/X: ShapeTx
Top Investors: New Enterprise Associates, Mission BioCapital, Decheng Capital, Willett Advisors LLC, Breton Capital Management
Description:
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.
$148M
$1M to $10M
Seattle, Washington, United States
2018-04-05
info(AT)shapetx.com
Francois Vigneault, John Suliman, Prashant Mali
101-250
2021-07-15
Private
© 2025 bioDAO.ai